Piper Sandler analyst David Westenberg lowered the firm’s price target on Neogen (NEOG) to $5 from $6.40 and keeps a Neutral rating on the shares. The firm cites a slower ramp in operating margins.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NEOG:
- Neogen to sell cleaners, disinfectants business to Kersia Group for $130M
- Neogen’s Strategic Shift and Market Positioning Justifies Buy Rating
- Neogen price target lowered to $6.40 from $13 at Piper Sandler
- Neogen price target lowered to $13 from $15 at Guggenheim
- Neogen Reports Q3 2025 Earnings Amid Challenges